Latest News, Events

Special Informational Webinar — After AZEDRA: Moving Forward Together

October 12, 2023

The news that production of AZEDRA, the only FDA-approved treatment for metastatic pheo para, will stop in spring 2024 has left us all with many questions. Dr. Dan Pryma and Dr. Erik Mittra will join us to answer some of them in this important informational webinar. You won’t want to miss this one — register now to submit your questions and receive the link to join!

Read our statement about this development here.

Registration for this event has closed. You can view the recorded webinar here.